The expression of a B cell marker (CD19), pro-inflammatory cytokines (IL1B, IL6, and TNF), and CD86 (a costimulatory cell marker) in the PBMCs of 80 MS patients and 34 matched healthy controls was analyzed. The gene discussed is IL6; the disease is myeloid sarcoma.